Particle.news
Download on the App Store

Bryan Johnson Reveals Autoimmune Gastritis and Pivots From Longevity to Cure Research

He has posted a staged research plan to analyze millions of immune cells as a path to targeted therapies for gastric autoimmunity and endometriosis.

Overview

  • Johnson publicly disclosed over the weekend that he has autoimmune gastritis, a chronic immune attack on stomach parietal cells that he described dramatically in interviews.
  • He said he welcomes the diagnosis and announced a research pivot, posting a multi-stage plan on X to sequence millions of immune cells to identify disease-causing cells and develop new therapies.
  • The revelation is striking because Johnson spent years and roughly $2 million a year on an intensive longevity regimen of strict diet, dozens of supplements, continuous biomarker monitoring and unusual self‑experiments.
  • Doctors and reporting note autoimmune gastritis is not currently curable but is often clinically managed with endoscopic surveillance, iron and vitamin B12 replacement, and monitoring for precancerous stomach changes.
  • Coverage frames the episode as a test of the longevity movement’s claim that exhaustive measurement prevents biological surprises and as a personal turning point that could reshape Johnson’s public work and funding priorities.